|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer显示文摘Allogeneic blood transfusion during liver resection for malignancies has been associated with an increased incidence of different types of complications: infectious complications, tumor recurrence, decreased survival. Even if there is clear evidence of transfusion-induced immunosuppression, it is difficult to demonstrate that transfusion is the only determinant factor that decisively affects the outcome. In any case there are several motivations to reduce the practice of blood transfusion. The advantages and drawbacks of different transfusion alternatives are reviewed here, emphasizing that surgeons and anesthetists who practice in centers with a high volume of liver resections, should be familiar with all the possible alternatives. | Gianlorenzo Dionigi Luigi Boni Francesca Rovera Stefano Rausei Salvatore Cuffari Giovanni Cantone Alessandro Bacuzzi Renzo Dionigi | 2009 | World Journal of Gastroenterology2009，15，32： | 10 |
| 2 | 胃的癌症的多模式的治疗显示文摘 Gastric cancer is the second leading cause of death from malignant disease worldwide.Although complete surgical resection remains the only curative modality for early stage gastric cancer,surgery alone only provides long-term survival in 20%of patients with advancedstage disease.To improve current results,it is necessary to consider multimodality treatment,including chemotherapy,radiotherapy and surgery.Recent clinical trials have shown survival benefit of combining different neoadjuvant or adjuvant protocols compared with surgery with curative intent.Furthermore,the implementation of chemotherapy with novel targeted agents could play an important role in the multimodal management of advanced gastric cancer.In this paper,we focus on a multidisciplinary approach in the treatment of gastric cancer and discuss future strategies to improve the outcome for these patients. | Ilaria Proserpio Stefano Rausei Sabrina Barzaghi Francesco Frattini Federica Galli Domenico Iovino Francesca Rovera Luigi Boni Gianlorenzo Dionigi Graziella Pinotti | 2014 | World Journal of Gastrointestinal Surgery2014，6，4： | 8 |
| 3 | Conversion surgery for gastric cancer patients:A review显示文摘Gastric cancer(GC) is the third most common cancer-related cause of death worldwide. In locally advanced tumors, neoadjuvant chemotherapy has recently been introduced in most international Western guidelines. For metastatic and unresectable disease, there is still debate regarding correct management and the role of surgery. The standard approach for stage IV GC is palliative chemotherapy. Over the last decade, an increasing number of M1 patients who responded to palliative regimens of induction chemotherapy have been subsequently undergone surgery with curative intent. The objective of the present review is to analyze the literature regarding this approach, known as 'conversion surgery', which has become one of the most commonly adopted therapeutic options. It is defined as a treat-ment aiming at an R0 resection after chemotherapy in initially unresectable tumors. The 13 retrospective studies analyzed, with a total of 411 patients treated with conversion therapy, clearly show that even if standardization of unresectable and metastatic criteria, post-chemotherapy resectability evaluation and timing of surgery has not yet been established, an R0 surgery after induction chemotherapy with partial or complete response seems to offer superior survival results than chemotherapy alone. Additional larger sample-size randomized control trials are needed to identify subgroups of well-stratified patients who could benefit from this multimodal approach. | Tommaso Zurleni Elson Gjoni Michele Altomare Stefano Rausei | 2018 | World Journal of Gastrointestinal Oncology2018，10，11： | 7 |
| 4 | seventh tumor-node-metastasis staging of gastric cancer: Five-year follow-up显示文摘Seventh tumor-node-metastasis(TNM) classification for gastric cancer,published in 2010,introduced changes in all of its three parameters with the aim to increase its accuracy in prognostication. The aim of this review is to analyze the efficacy of these changes and their implication in clinical practice. We reviewed relevant Literature concerning staging systems in gastric cancer from 2010 up to March 2016. Adenocarcinoma of the esophago-gastric junction still remains a debated entity,due to its peculiar anatomical and histological situation: further improvement in its staging are required. Concerning distant metastases,positive peritoneal cytology has been adopted as a criterion to define metastatic disease: however,its search in clinical practice is still far from being routinely performed,as staging laparoscopy has not yet reached wide diffusion. Regarding definition of T and N: in the era of multimodal treatment these parameters should more influence both staging and surgery. The changes about T-staging suggested some modifications in clinical practice. Differently,many controversies on lymph node staging are still ongoing,with the proposal of alternative classification systems in order to minimize the extent of lymphadenectomy. The next TNM classification should take into account all of these aspects to improve its accuracy and the comparability of prognosis in patients from both Eastern and Western world. | Stefano Rausei Laura Ruspi Federica Galli Vincenzo Pappalardo Giuseppe Di Rocco Francesco Martignoni Francesco Frattini Francesca Rovera Luigi Boni Gianlorenzo Dionigi | 2016 | World Journal of Gastroenterology2016，22，34： | 2 |
| 5 | Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer显示文摘 | D. D’Ugo R. Persiani S. Rausei A. Biondi V. Vigorita S. Boccia R. Ricci | 2006 | European Journal of Surgical Oncology2006，，10： | 2 |
| 6 | Preoperative treatment and surgery in gastric cancer: friends or foes?显示文摘 | Domenico D’Ugo Stefano Rausei Alberto Biondi Roberto Persiani | 2009 | Lancet Oncology2009，，2： | 2 |
| 7 | In advanced gastric cancer:Prognosis and treatment of patients with positive peritoneal cytology显示文摘Positive peritoneal cytology in gastric cancer is classified as M1 disease by the 7thEdition of American Joint Committee on Cancer staging system.With the introduction of laparoscopy and peritoneal washing cytology in the staging of gastric cancer a new category of patients has been identified.These are patients with no macroscopic peritoneal metastases but with peritoneal cytology positive(P0C1).Prognosis and treatment of such patientsrepresent a controversial issue.We evaluate the state of the art of staging system in gastric cancer and discusss tandardisation in staging and treatment procedures.There is still a lack of uniformity in the use of laparoscopy with peritoneal cytology in clinical decision making and in the surgical treatment for gastric cancer.Survival of this patient subset remains poor.Multimodal therapies and new therapeutic strategies are required to improve the survival of these patients. | Francesco Frattini Stefano Rausei Corrado Chiappa Francesca Rovera Luigi Boni Gianlorenzo Dionigi | 2013 | World Journal of Gastrointestinal Surgery2013，5，5： | 2 |
| 8 | The safety of energy-based devices in open thyroidectomy: a prospective, randomised study comparing the LigaSure? (LF1212) and the Harmonic? FOCUS显示文摘 | Gianlorenzo Dionigi Luigi Boni Stefano Rausei Francesco Frattini Cesare Ferrari Alberto Mangano Andrea Leotta Marco Franchin | 2012 | Langenbeck’s Archives of Surgery2012，，5： | 2 |
| 9 | How does the 7th TNM edition fit in gastric cancer management?显示文摘 | Rausei S Dionigi G Boni L | 2011 | Ann Surg Oncol2011，18，5： | 1 |
| 10 | History of splenctomy显示文摘 | Dionigi R Boni L Rausei S | 2013 | Int J Surg2013，11，1： | 1 |
| 11 | Bladder reconslitution with bone marrow derived stem cells see ded on small intestinal sutmmcosa improves morpholog ical and molecular composition显示文摘 | Chung S Y Krivorov N P Rausei V et at | 2005 | J Urol2005，174，： | 1 |
| 12 | Nodule size and fine-needle aspiration biopsy:diagnostic challenges for thyroid malignancy显示文摘 | Rausei S Dionigi G Frattini F | | 0，，： | 1 |
| 13 | Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition显示文摘 | Chung SY Krivorov NP Rausei V | 2005 | J Urol2005，174，1： | 1 |
| 14 | Bladder recon-stitution with bone marrow derived stem cells seeded on small in-testinal submucosa improves morphological and molecular com-position显示文摘 | CHUNG SY KRIVOROV NP RAUSEI V | 2005 | J Urol2005，174，1： | 1 |
| 15 | Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification 显示文摘 | Rausei S Dionigi G Boni L | 2011 | Cancer2011，117，12： | 1 |
| 16 | Prognosis and treatment of patients with positive peritoneal cytology in advanced gastric cancer显示文摘 | Frattini F Rausei S Chiappa C | 2013 | World J Gastrointest Surg2013，275，5： | 1 |
| 17 | Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D22 gastrectomy 显示文摘 | Persiani R D' Ugo D Rausei S | 2005 | J Surg Oncol2005，89，4： | 1 |
| 18 | Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2- gastrectomy显示文摘 | PERSIANI R D UGO D RAUSEI S | 2005 | J Surg Oncol2005，89，4： | 1 |
| 19 | How does the 7th TNM edition fit in gastric cancer management 显示文摘 | Rausei S Dionigi G Boni L | 2010 | Ann Surg Oncol2010，9，1： | 1 |
| 20 | A decade in gastric cancer curative surgery:Evidence of progress(1999-2009)显示文摘To investigate the progress in evidence-based surgical treatment of non-metastatic gastric cancer,we re- viewed the last ten years'literature.The data used in this review were identified by searches made on MED-LINE,Current Contents,PubMed,and other references taken from relevant original articles(on prospective and retrospective studies)concerning gastric cancer surgery.Only papers published in English between January 1999 and December 2009 were selected.Data from ongoing studies were obtained in December 2009, from the trials registry of the United States National Institutes of Health(http://gffzzdbf2e3d08f4046d0hwwxuxvxuncnu6pnw.ffgz.tsg.suse.edu.cn).The citations list was presented according to evidence based relevance(i.e.,randomized controlled trials,pro- spective studies,retrospective series).In the last ten years,many challenges have been faced relating to the extension of gastric resection and nodal dissection as well as surgical timing,but we found only limited evidence,regardless of latitude of study.The ongoing phase-Ⅲ trials may provide answers that will be valid for the coming decades,and which may bring definitive answers for the currently unresolved questions. | Stefano Rausei Gianlorenzo Dionigi Francesca Rovera Luigi Boni Caterina Valerii Luisa Giavarini Francesco Frattini Renzo Dionigi | 2012 | World Journal of Gastrointestinal Surgery2012，4，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员